Yazdi K. Pithavala

3.1k total citations
65 papers, 2.5k citations indexed

About

Yazdi K. Pithavala is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yazdi K. Pithavala has authored 65 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 34 papers in Oncology and 30 papers in Molecular Biology. Recurrent topics in Yazdi K. Pithavala's work include Lung Cancer Treatments and Mutations (26 papers), Renal cell carcinoma treatment (19 papers) and Pancreatic and Hepatic Oncology Research (11 papers). Yazdi K. Pithavala is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Renal cell carcinoma treatment (19 papers) and Pancreatic and Hepatic Oncology Research (11 papers). Yazdi K. Pithavala collaborates with scholars based in United States, Italy and Spain. Yazdi K. Pithavala's co-authors include George Wilding, Heidi Steinfeldt, May Garrett, Steven D. Reich, Roy S. Herbst, Michael A. Tortorici, Hope S. Rugo, Glenn Liu, John W. Park and Sinil Kim and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Yazdi K. Pithavala

64 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yazdi K. Pithavala United States	25	1.2k	1.2k	1.1k	581	213	65	2.5k
Susan Ellard Canada	27	964 0.8×	823 0.7×	968 0.9×	526 0.9×	121 0.6×	81	2.4k
Katherine Liau United States	19	843 0.7×	861 0.7×	1.1k 1.0×	441 0.8×	122 0.6×	36	2.0k
R. Delva France	21	1.3k 1.0×	657 0.6×	1.3k 1.2×	538 0.9×	196 0.9×	99	2.5k
Nielka P. van Erp Netherlands	30	1.1k 0.9×	918 0.8×	1.1k 1.0×	493 0.8×	543 2.5×	122	2.9k
Giorgio Massimini Italy	16	861 0.7×	899 0.8×	1.3k 1.2×	705 1.2×	561 2.6×	33	2.8k
Jackie Walling United States	16	878 0.7×	671 0.6×	1.0k 0.9×	252 0.4×	129 0.6×	45	1.9k
Jean Charles Soria France	25	965 0.8×	1.5k 1.3×	1.2k 1.1×	561 1.0×	73 0.3×	48	3.1k
Kristi A. Boehm United States	24	736 0.6×	495 0.4×	1.5k 1.4×	720 1.2×	135 0.6×	77	2.3k
Fabio A.B. Schutz United States	21	1.2k 0.9×	638 0.6×	1.4k 1.3×	281 0.5×	150 0.7×	46	2.9k
Panos Fidias United States	25	1.8k 1.5×	925 0.8×	1.7k 1.6×	276 0.5×	105 0.5×	58	3.0k

Countries citing papers authored by Yazdi K. Pithavala

Since Specialization

Citations

This map shows the geographic impact of Yazdi K. Pithavala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yazdi K. Pithavala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yazdi K. Pithavala more than expected).

Fields of papers citing papers by Yazdi K. Pithavala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yazdi K. Pithavala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yazdi K. Pithavala. The network helps show where Yazdi K. Pithavala may publish in the future.

Co-authorship network of co-authors of Yazdi K. Pithavala

This figure shows the co-authorship network connecting the top 25 collaborators of Yazdi K. Pithavala. A scholar is included among the top collaborators of Yazdi K. Pithavala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yazdi K. Pithavala. Yazdi K. Pithavala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jerry, Yazdi K. Pithavala, Jason Gong, et al.. (2021). The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants. Clinical Pharmacokinetics. 60(10). 1303–1312. 7 indexed citations

Xu, Huiping, et al.. (2021). Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy Participants. Clinical Pharmacology in Drug Development. 10(11). 1395–1404. 4 indexed citations

Chen, Joseph, Huiping Xu, Sylvester Pawlak, et al.. (2019). The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants. Advances in Therapy. 37(2). 745–758. 24 indexed citations

Bauer, Todd M., Alice T. Shaw, Melissa L. Johnson, et al.. (2018). MA08.05 Brain Penetration of Lorlatinib and Cumulative Incidence Rates for CNS and Non CNS Progression from a Phase 1/2 Study. Journal of Thoracic Oncology. 13(10). S382–S383. 4 indexed citations

Chen, Ying, Michael A. Tortorici, May Garrett, et al.. (2015). Axitinib plasma pharmacokinetics and ethnic differences. Investigational New Drugs. 33(2). 521–532. 23 indexed citations

Tortorici, Michael A., Ezra E.W. Cohen, Yazdi K. Pithavala, et al.. (2014). Pharmacokinetics of single-agent axitinib across multiple solid tumor types. Cancer Chemotherapy and Pharmacology. 74(6). 1279–1289. 13 indexed citations

Chen, Ying, Michael A. Tortorici, May Garrett, et al.. (2013). Clinical Pharmacology of Axitinib. Clinical Pharmacokinetics. 52(9). 713–725. 99 indexed citations

Pithavala, Yazdi K., Ying Chen, Melvin Toh, et al.. (2012). Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers. Cancer Chemotherapy and Pharmacology. 70(1). 103–112. 36 indexed citations

Brennan, Meghan, et al.. (2011). Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics. European Journal of Clinical Pharmacology. 68(5). 645–655. 38 indexed citations

10.

Spano, Jean‐Philippe, Malcolm J. Moore, Yazdi K. Pithavala, et al.. (2011). Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancer. Investigational New Drugs. 30(4). 1531–1539. 15 indexed citations

11.

Pithavala, Yazdi K., Sadayappan V. Rahavendran, May Garrett, et al.. (2010). Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers. Investigational New Drugs. 30(1). 273–281. 53 indexed citations

12.

Tortorici, Michael A., Melvin Toh, Sadayappan V. Rahavendran, et al.. (2010). Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics. Investigational New Drugs. 29(6). 1370–1380. 47 indexed citations

13.

Pithavala, Yazdi K., Melvin Toh, May Garrett, et al.. (2008). Effect of food on the pharmacokinetics of Axitinib (AG-013736) in healthy volunteers. Cancer Research. 68. 233–233. 3 indexed citations

14.

Spano, Jean‐Philippe, Catherine Chodkiewicz, Joan Maurel, et al.. (2008). Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study. The Lancet. 371(9630). 2101–2108. 204 indexed citations

15.

Cohen, Roger B., Mark Kozloff, Yazdi K. Pithavala, et al.. (2007). Axitinib (AG-013736; AG) in combination with paclitaxel (P)/carboplatin (C) in patients (pts) with advanced solid tumors. Molecular Cancer Therapeutics. 6. 1 indexed citations

16.

Spano, Jean‐Philippe, Catherine Chodkiewicz, Joan Maurel, et al.. (2007). A randomized phase II study of axitinib (AG-013736) and gemcitabine versus gemcitabine in advanced pancreatic cancer, preceded by a phase I component. Journal of Clinical Oncology. 25(18_suppl). 4551–4551. 14 indexed citations

17.

Yamazaki, Shinji, Maren L. Grazzini, David Romero, et al.. (2005). PK/PD modeling based on mouse xenograft tumor growth inhibition and the correlation to clinical exposure for VEGF/PDGF receptor tyrosine kinase inhibitor AG-013736. Cancer Research. 65. 705–706. 2 indexed citations

18.

Bissett, D., Howard L. McLeod, Mary Collier, et al.. (2001). Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034. British Journal of Cancer. 84(3). 308–312. 22 indexed citations

19.

Pithavala, Yazdi K., William D. Heizer, Alan Parr, Robin O'Connor‐Semmes, & Kim L. R. Brouwer. (1998). Use of the InteliSite® Capsule to Study Ranitidine Absorption from Various Sites Within the Human Intestinal Tract. Pharmaceutical Research. 15(12). 1869–1875. 25 indexed citations

20.

Pithavala, Yazdi K., et al.. (1995). Retinoid Absorption from Simple and Mixed Micelles in the Rat Intestine. Journal of Pharmaceutical Sciences. 84(11). 1360–1365. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact